Henden, A. S., Lineburg, K. E., Panikkar, A., Mahajan, A., Nelles, R., Wright, E., . . . Smith, C. (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Wiley.
Chicago Style (17th ed.) CitationHenden, Andrea S., et al. Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific Adoptive T‐cell Therapy for Refractory Viral Infection and End Organ Disease. Wiley, 2025.
MLA (9th ed.) CitationHenden, Andrea S., et al. Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific Adoptive T‐cell Therapy for Refractory Viral Infection and End Organ Disease. Wiley, 2025.
Warning: These citations may not always be 100% accurate.